Structure

Physi-Chem Properties

Molecular Weight:  476.35
Volume:  508.672
LogP:  4.772
LogD:  3.896
LogS:  -4.559
# Rotatable Bonds:  3
TPSA:  75.99
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  5
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.528
Synthetic Accessibility Score:  5.303
Fsp3:  0.966
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.752
MDCK Permeability:  2.1702353478758596e-05
Pgp-inhibitor:  0.999
Pgp-substrate:  0.256
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.726
30% Bioavailability (F30%):  0.751

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.191
Plasma Protein Binding (PPB):  83.94645690917969%
Volume Distribution (VD):  1.616
Pgp-substrate:  16.636857986450195%

ADMET: Metabolism

CYP1A2-inhibitor:  0.017
CYP1A2-substrate:  0.415
CYP2C19-inhibitor:  0.013
CYP2C19-substrate:  0.88
CYP2C9-inhibitor:  0.065
CYP2C9-substrate:  0.022
CYP2D6-inhibitor:  0.008
CYP2D6-substrate:  0.084
CYP3A4-inhibitor:  0.676
CYP3A4-substrate:  0.342

ADMET: Excretion

Clearance (CL):  10.49
Half-life (T1/2):  0.264

ADMET: Toxicity

hERG Blockers:  0.693
Human Hepatotoxicity (H-HT):  0.306
Drug-inuced Liver Injury (DILI):  0.555
AMES Toxicity:  0.008
Rat Oral Acute Toxicity:  0.876
Maximum Recommended Daily Dose:  0.071
Skin Sensitization:  0.717
Carcinogencity:  0.288
Eye Corrosion:  0.415
Eye Irritation:  0.024
Respiratory Toxicity:  0.96

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC209592

Natural Product ID:  NPC209592
Common Name*:   HABDCYTZKFMLRY-QSXVJOPHSA-N
IUPAC Name:   n.a.
Synonyms:   10,13-Dibenzoyltaxacustin
Standard InCHIKey:  HABDCYTZKFMLRY-QSXVJOPHSA-N
Standard InCHI:  InChI=1S/C42H48O14/c1-22-29(54-37(47)27-15-11-9-12-16-27)20-41(39(6,7)49)32(22)33(55-38(48)28-17-13-10-14-18-28)35(52-24(3)44)40(8)30(51-23(2)43)19-31-42(21-50-31,56-26(5)46)34(40)36(41)53-25(4)45/h9-18,29-31,33-36,49H,19-21H2,1-8H3/t29-,30-,31+,33+,34-,35-,36-,40+,41-,42-/m0/s1
SMILES:  CC(=O)O[C@H]1[C@@H]2[C@@]3(CO[C@@H]3C[C@@H]([C@@]2(C)[C@H]([C@@H](C2=C([C@H](C[C@@]12C(O)(C)C)OC(=O)c1ccccc1)C)OC(=O)c1ccccc1)OC(=O)C)OC(=O)C)OC(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL447609
PubChem CID:   12038773
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0000676] Taxanes and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. leaf n.a. DOI[10.1016/j.tet.2004.10.110]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. twig n.a. DOI[10.1016/j.tet.2004.10.110]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota leaves and twigs n.a. n.a. PMID[12502326]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. PMID[15679325]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. twig n.a. PMID[15679325]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. leaf n.a. PMID[15679325]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. PMID[18220355]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 = 9.69 ug.mL-1 PMID[464269]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 20.0 ug.mL-1 PMID[464269]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC209592 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC48599
0.9928 High Similarity NPC473760
0.9786 High Similarity NPC31829
0.964 High Similarity NPC125882
0.9635 High Similarity NPC266374
0.9571 High Similarity NPC20255
0.95 High Similarity NPC92867
0.95 High Similarity NPC311825
0.9429 High Similarity NPC34943
0.9301 High Similarity NPC76103
0.9296 High Similarity NPC240115
0.9286 High Similarity NPC192658
0.9281 High Similarity NPC162613
0.9281 High Similarity NPC87934
0.9214 High Similarity NPC16912
0.9209 High Similarity NPC9905
0.9172 High Similarity NPC96308
0.9155 High Similarity NPC95810
0.9155 High Similarity NPC472573
0.9155 High Similarity NPC125106
0.9155 High Similarity NPC163719
0.9155 High Similarity NPC25768
0.9155 High Similarity NPC188865
0.9155 High Similarity NPC11685
0.9155 High Similarity NPC476974
0.9155 High Similarity NPC57628
0.9155 High Similarity NPC472569
0.9155 High Similarity NPC95265
0.9155 High Similarity NPC70716
0.9155 High Similarity NPC472570
0.9143 High Similarity NPC97667
0.9143 High Similarity NPC171207
0.9143 High Similarity NPC90614
0.9116 High Similarity NPC473611
0.9091 High Similarity NPC476973
0.9091 High Similarity NPC29704
0.9091 High Similarity NPC171525
0.9091 High Similarity NPC174982
0.9091 High Similarity NPC96903
0.9091 High Similarity NPC473088
0.9091 High Similarity NPC184817
0.9091 High Similarity NPC471104
0.9091 High Similarity NPC177940
0.9091 High Similarity NPC470159
0.9091 High Similarity NPC472575
0.9091 High Similarity NPC472572
0.9091 High Similarity NPC472571
0.9091 High Similarity NPC472568
0.9091 High Similarity NPC158663
0.9091 High Similarity NPC470157
0.9091 High Similarity NPC200471
0.9091 High Similarity NPC469349
0.9091 High Similarity NPC70403
0.9085 High Similarity NPC163087
0.9078 High Similarity NPC87448
0.9078 High Similarity NPC118080
0.9078 High Similarity NPC291599
0.9078 High Similarity NPC27377
0.9078 High Similarity NPC41481
0.9078 High Similarity NPC97947
0.9078 High Similarity NPC472576
0.9028 High Similarity NPC474935
0.9028 High Similarity NPC473602
0.9021 High Similarity NPC470152
0.9021 High Similarity NPC475759
0.9021 High Similarity NPC475122
0.9021 High Similarity NPC241951
0.9007 High Similarity NPC473085
0.9007 High Similarity NPC100913
0.9007 High Similarity NPC184747
0.9007 High Similarity NPC4341
0.9007 High Similarity NPC275592
0.9007 High Similarity NPC473112
0.9007 High Similarity NPC476094
0.9007 High Similarity NPC48017
0.9007 High Similarity NPC200592
0.9007 High Similarity NPC473613
0.9007 High Similarity NPC147880
0.9007 High Similarity NPC473109
0.9007 High Similarity NPC211137
0.9007 High Similarity NPC473758
0.9007 High Similarity NPC473060
0.9007 High Similarity NPC473081
0.9007 High Similarity NPC43241
0.8993 High Similarity NPC66761
0.8993 High Similarity NPC291638
0.8993 High Similarity NPC17877
0.8993 High Similarity NPC195647
0.8993 High Similarity NPC472577
0.8986 High Similarity NPC469730
0.8986 High Similarity NPC132599
0.8986 High Similarity NPC473632
0.8966 High Similarity NPC327031
0.8966 High Similarity NPC281717
0.8958 High Similarity NPC472556
0.8951 High Similarity NPC95449
0.8944 High Similarity NPC224491
0.894 High Similarity NPC476077
0.8936 High Similarity NPC475652
0.8936 High Similarity NPC210591
0.8936 High Similarity NPC214550
0.8921 High Similarity NPC474608
0.8904 High Similarity NPC476975
0.8904 High Similarity NPC266265
0.8904 High Similarity NPC92293
0.8904 High Similarity NPC270590
0.8904 High Similarity NPC301556
0.8904 High Similarity NPC471101
0.8897 High Similarity NPC312393
0.8889 High Similarity NPC38696
0.8881 High Similarity NPC34012
0.8873 High Similarity NPC472547
0.8865 High Similarity NPC283375
0.8865 High Similarity NPC183122
0.8844 High Similarity NPC470245
0.8844 High Similarity NPC473214
0.8819 High Similarity NPC246480
0.8819 High Similarity NPC191082
0.8819 High Similarity NPC475429
0.8819 High Similarity NPC139067
0.8819 High Similarity NPC270498
0.8819 High Similarity NPC473673
0.8819 High Similarity NPC147217
0.8819 High Similarity NPC177340
0.88 High Similarity NPC326235
0.88 High Similarity NPC323001
0.8794 High Similarity NPC472545
0.8794 High Similarity NPC472551
0.8784 High Similarity NPC470153
0.8776 High Similarity NPC473215
0.8767 High Similarity NPC478263
0.8759 High Similarity NPC51314
0.8759 High Similarity NPC67777
0.8759 High Similarity NPC470231
0.875 High Similarity NPC472546
0.8742 High Similarity NPC318447
0.8742 High Similarity NPC322048
0.8732 High Similarity NPC39549
0.8716 High Similarity NPC476173
0.8707 High Similarity NPC217918
0.8699 High Similarity NPC478264
0.869 High Similarity NPC477894
0.8667 High Similarity NPC471135
0.8658 High Similarity NPC51602
0.8633 High Similarity NPC147561
0.8627 High Similarity NPC326328
0.8627 High Similarity NPC309991
0.8627 High Similarity NPC323356
0.8627 High Similarity NPC471138
0.8609 High Similarity NPC34066
0.8609 High Similarity NPC282239
0.86 High Similarity NPC469648
0.86 High Similarity NPC138641
0.86 High Similarity NPC22571
0.86 High Similarity NPC477905
0.86 High Similarity NPC233581
0.86 High Similarity NPC472548
0.86 High Similarity NPC469647
0.86 High Similarity NPC145649
0.86 High Similarity NPC283875
0.8592 High Similarity NPC477893
0.8591 High Similarity NPC469448
0.8591 High Similarity NPC91730
0.8581 High Similarity NPC132652
0.8571 High Similarity NPC127857
0.8562 High Similarity NPC131966
0.8562 High Similarity NPC191387
0.8562 High Similarity NPC91703
0.8562 High Similarity NPC319404
0.8553 High Similarity NPC106895
0.8553 High Similarity NPC475638
0.8553 High Similarity NPC475548
0.8553 High Similarity NPC290683
0.854 High Similarity NPC284022
0.8533 High Similarity NPC197037
0.8533 High Similarity NPC471103
0.8531 High Similarity NPC472374
0.8531 High Similarity NPC472372
0.8526 High Similarity NPC471134
0.8516 High Similarity NPC55744
0.8497 Intermediate Similarity NPC472393
0.8493 Intermediate Similarity NPC182869
0.8487 Intermediate Similarity NPC26033
0.8487 Intermediate Similarity NPC469422
0.8487 Intermediate Similarity NPC228204
0.8487 Intermediate Similarity NPC472549
0.8483 Intermediate Similarity NPC477904
0.8483 Intermediate Similarity NPC183270
0.8472 Intermediate Similarity NPC205305
0.8472 Intermediate Similarity NPC327511
0.8472 Intermediate Similarity NPC475373
0.8467 Intermediate Similarity NPC254558
0.8467 Intermediate Similarity NPC7095
0.8467 Intermediate Similarity NPC112216
0.8462 Intermediate Similarity NPC478125
0.8462 Intermediate Similarity NPC477896
0.8446 Intermediate Similarity NPC471107
0.8446 Intermediate Similarity NPC471100
0.8442 Intermediate Similarity NPC471102
0.8442 Intermediate Similarity NPC469399

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC209592 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7961 Intermediate Similarity NPD7236 Approved
0.7821 Intermediate Similarity NPD7239 Suspended
0.7771 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.774 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7711 Intermediate Similarity NPD7799 Discontinued
0.7633 Intermediate Similarity NPD8368 Discontinued
0.7616 Intermediate Similarity NPD8434 Phase 2
0.7602 Intermediate Similarity NPD8407 Phase 2
0.7529 Intermediate Similarity NPD8435 Approved
0.7529 Intermediate Similarity NPD8361 Approved
0.7529 Intermediate Similarity NPD8360 Approved
0.7415 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD7741 Discontinued
0.7378 Intermediate Similarity NPD7058 Phase 2
0.7378 Intermediate Similarity NPD7057 Phase 3
0.7356 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD8127 Discontinued
0.7278 Intermediate Similarity NPD8485 Approved
0.7267 Intermediate Similarity NPD7008 Discontinued
0.725 Intermediate Similarity NPD6273 Approved
0.7219 Intermediate Similarity NPD3764 Approved
0.7171 Intermediate Similarity NPD7961 Discontinued
0.7158 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD4628 Phase 3
0.7152 Intermediate Similarity NPD7819 Suspended
0.7113 Intermediate Similarity NPD2629 Approved
0.7113 Intermediate Similarity NPD5951 Approved
0.7107 Intermediate Similarity NPD6190 Approved
0.7071 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD4198 Discontinued
0.7052 Intermediate Similarity NPD5844 Phase 1
0.7044 Intermediate Similarity NPD8166 Discontinued
0.7022 Intermediate Similarity NPD8150 Discontinued
0.7013 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.6988 Remote Similarity NPD37 Approved
0.6964 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6964 Remote Similarity NPD4967 Phase 2
0.6964 Remote Similarity NPD4966 Approved
0.6964 Remote Similarity NPD4965 Approved
0.6962 Remote Similarity NPD7702 Clinical (unspecified phase)
0.6948 Remote Similarity NPD6663 Approved
0.6946 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6936 Remote Similarity NPD7473 Discontinued
0.6932 Remote Similarity NPD7685 Pre-registration
0.6929 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6929 Remote Similarity NPD2182 Approved
0.6923 Remote Similarity NPD7075 Discontinued
0.6909 Remote Similarity NPD7458 Discontinued
0.6908 Remote Similarity NPD5736 Approved
0.6892 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6882 Remote Similarity NPD6234 Discontinued
0.6875 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6868 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6864 Remote Similarity NPD7768 Phase 2
0.6862 Remote Similarity NPD7497 Discontinued
0.686 Remote Similarity NPD6232 Discontinued
0.6853 Remote Similarity NPD7094 Approved
0.6853 Remote Similarity NPD6858 Approved
0.6845 Remote Similarity NPD5760 Phase 2
0.6845 Remote Similarity NPD5761 Phase 2
0.6832 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6832 Remote Similarity NPD7003 Approved
0.6824 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6824 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6824 Remote Similarity NPD5126 Approved
0.6824 Remote Similarity NPD5125 Phase 3
0.6805 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6792 Remote Similarity NPD2935 Discontinued
0.6788 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6768 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6766 Remote Similarity NPD4380 Phase 2
0.6766 Remote Similarity NPD6599 Discontinued
0.676 Remote Similarity NPD8313 Approved
0.676 Remote Similarity NPD8312 Approved
0.6758 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6753 Remote Similarity NPD8462 Phase 1
0.6752 Remote Similarity NPD6355 Discontinued
0.6746 Remote Similarity NPD8455 Phase 2
0.6744 Remote Similarity NPD5494 Approved
0.6742 Remote Similarity NPD6765 Approved
0.6742 Remote Similarity NPD6764 Approved
0.6735 Remote Similarity NPD7610 Discontinued
0.6733 Remote Similarity NPD6287 Discontinued
0.673 Remote Similarity NPD2799 Discontinued
0.6728 Remote Similarity NPD3750 Approved
0.6726 Remote Similarity NPD7411 Suspended
0.6715 Remote Similarity NPD1238 Approved
0.6707 Remote Similarity NPD3226 Approved
0.6707 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6707 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6707 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6706 Remote Similarity NPD3817 Phase 2
0.6706 Remote Similarity NPD5402 Approved
0.6705 Remote Similarity NPD7228 Approved
0.6705 Remote Similarity NPD7199 Phase 2
0.6691 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6691 Remote Similarity NPD1930 Approved
0.6691 Remote Similarity NPD1929 Approved
0.6687 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6686 Remote Similarity NPD6801 Discontinued
0.6685 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6685 Approved
0.6647 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6646 Remote Similarity NPD6005 Phase 3
0.6646 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6646 Remote Similarity NPD6004 Phase 3
0.6646 Remote Similarity NPD7266 Discontinued
0.6646 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6646 Remote Similarity NPD6002 Phase 3
0.6646 Remote Similarity NPD2346 Discontinued
0.6646 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6646 Remote Similarity NPD230 Phase 1
0.6644 Remote Similarity NPD690 Clinical (unspecified phase)
0.6643 Remote Similarity NPD164 Approved
0.6629 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6627 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6625 Remote Similarity NPD3748 Approved
0.6624 Remote Similarity NPD8032 Phase 2
0.6624 Remote Similarity NPD6233 Phase 2
0.6616 Remote Similarity NPD8404 Phase 2
0.6606 Remote Similarity NPD6799 Approved
0.6603 Remote Similarity NPD7095 Approved
0.6594 Remote Similarity NPD7798 Approved
0.6593 Remote Similarity NPD6785 Approved
0.6593 Remote Similarity NPD6784 Approved
0.6591 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6588 Remote Similarity NPD1934 Approved
0.6587 Remote Similarity NPD5403 Approved
0.6584 Remote Similarity NPD2438 Suspended
0.6584 Remote Similarity NPD5408 Approved
0.6584 Remote Similarity NPD5404 Approved
0.6584 Remote Similarity NPD5406 Approved
0.6584 Remote Similarity NPD5405 Approved
0.6582 Remote Similarity NPD4140 Approved
0.6577 Remote Similarity NPD9545 Approved
0.6571 Remote Similarity NPD6647 Phase 2
0.6566 Remote Similarity NPD2532 Approved
0.6566 Remote Similarity NPD2534 Approved
0.6566 Remote Similarity NPD5401 Approved
0.6566 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6566 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6566 Remote Similarity NPD2533 Approved
0.6562 Remote Similarity NPD7097 Phase 1
0.6561 Remote Similarity NPD2313 Discontinued
0.6561 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6561 Remote Similarity NPD6798 Discontinued
0.6556 Remote Similarity NPD6559 Discontinued
0.6556 Remote Similarity NPD7240 Approved
0.6543 Remote Similarity NPD5763 Approved
0.6543 Remote Similarity NPD5762 Approved
0.6538 Remote Similarity NPD6832 Phase 2
0.6532 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6528 Remote Similarity NPD2067 Discontinued
0.6525 Remote Similarity NPD5909 Discontinued
0.6524 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6524 Remote Similarity NPD4110 Phase 3
0.6519 Remote Similarity NPD7713 Phase 3
0.6519 Remote Similarity NPD7715 Approved
0.6519 Remote Similarity NPD7714 Approved
0.6517 Remote Similarity NPD3818 Discontinued
0.6516 Remote Similarity NPD6085 Phase 2
0.6516 Remote Similarity NPD5740 Clinical (unspecified phase)
0.6508 Remote Similarity NPD7700 Phase 2
0.6508 Remote Similarity NPD7699 Phase 2
0.6503 Remote Similarity NPD970 Clinical (unspecified phase)
0.6497 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6497 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6497 Remote Similarity NPD6166 Phase 2
0.6494 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6483 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6481 Remote Similarity NPD2796 Approved
0.648 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6477 Remote Similarity NPD7229 Phase 3
0.6477 Remote Similarity NPD8319 Approved
0.6477 Remote Similarity NPD8320 Phase 1
0.6471 Remote Similarity NPD7028 Phase 2
0.6471 Remote Similarity NPD1608 Approved
0.6467 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6467 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6454 Remote Similarity NPD5765 Approved
0.6453 Remote Similarity NPD2801 Approved
0.6453 Remote Similarity NPD1465 Phase 2
0.6452 Remote Similarity NPD2797 Approved
0.6444 Remote Similarity NPD7074 Phase 3
0.6438 Remote Similarity NPD6912 Phase 3
0.6437 Remote Similarity NPD3749 Approved
0.6436 Remote Similarity NPD6534 Approved
0.6436 Remote Similarity NPD6535 Approved
0.6425 Remote Similarity NPD7435 Discontinued
0.642 Remote Similarity NPD1510 Phase 2
0.642 Remote Similarity NPD6959 Discontinued
0.642 Remote Similarity NPD4308 Phase 3
0.642 Remote Similarity NPD7305 Phase 1
0.642 Remote Similarity NPD7033 Discontinued
0.641 Remote Similarity NPD2798 Approved
0.6408 Remote Similarity NPD1237 Approved
0.6405 Remote Similarity NPD4807 Approved
0.6405 Remote Similarity NPD4806 Approved
0.6404 Remote Similarity NPD7997 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data